Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Current breakthroughs in cancer immunotherapy have been based on studies published by my own laboratory and by other labs which show that ...
“Johns Hopkins” cancer update emails are a hoax - Cancer Research UK (blog)
There are 90 different clinical trials in various stages around the country today testing pembrolizumab — the hottest new immunotherapy cancer drug ...
“Prostate cancer resistant to conventional treatment could be all but wiped out by a therapy that boosts theimmune system,” the Daily Mail reports.
... real view into true cures,” Gilliland said, adding that this insight has led to an understanding of “redirecting the immune system" to eradicate cancer.
An American biotech firm is developing a new antibody to combat cancer that also improves the patient's feeling of well-being. Its work is based on ...
A partnership between the Pancreatic Cancer Action Network and Perthera, a self-described “concierge” for molecular diagnostic testing, is aiming to ...
The addition of masitinib to gemcitabine significantly prolonged OS in patients with advanced pancreatic cancer who overexpressed ACOX1 or had ...
Colorectal cancer is the second most common cancer in women and the third most ... Nut consumption and risk of pancreatic cancer in women
But this virus is genetically- engineered to attack only cancer cells, not ... “Pancreatic cancer, it looks like it can kill those tumors, but we think this could ...
PURPOSE: Patients with recurrent or persistent high-grade non-muscle-invasive bladder cancer after bacille Calmette-Guérin (BCG) therapy are ...
Bladder cancer relapse and treatment failure in most patients have often been attributed to chemo-resistance in tumor cells and metastasis. Emerging ...
PURPOSE: To characterize the effect of palliative care provided concurrently with usual urologic care for patients with bladder cancer undergoing ...
OBJECTIVE: To examine the association of travel distance on quality and survival outcome measures forbladder cancer patients undergoing radical ...
The Phase 2 bladder cancer trial is being conducted by Mirati and is using Foundation Medicine's comprehensive genomic profile to screen patients ...
MATERIALS AND METHODS: We studied 150 consecutive cases of muscle-invasive bladder cancer that received GC NAC followed by open RC ...
BACKGROUND: The need to prevent reflux in the construction of an orthotopic ileal neobladder (ONB) is controversial. We designed the USC-STAR ...
Science Daily Cancer News
Researchers discover that particular genetic fragments, of a type of RNA known as transfer RNA, or tRNA, appear to be capable of reducing the growth and spread of breast cancer cells.
Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions one expert, who adds that drug reviewers don't look at the long term survival of patients who take them.
Three-dimensional cultures (or 'organoids') derived from the tumors of cancer patients closely replicate key properties of the original tumors, reveals a study. These 'organoid' cultures are amenable to large-scale drug screens for the detection of genetic changes associated with drug sensitivity and pave the way for personalized treatment approaches that could optimize clinical outcomes in cancer patients.
The cause of some cancers, including breast cancer and leukemia, is better understood, thanks to recent research. In the new study, the researchers found that too much of a key protein, called cyclin E, slows down DNA replication and introduces potentially harmful cancer-linked mutations when cells divide.
A team of scientists has uncovered a big clue to how bacteria may promote some colon cancers. The study used novel metabolomic technologies to reveal molecular evidence suggesting a vicious circle in which cancerous changes in colon cells promote the growth of bacterial conglomerations called biofilms, and biofilms in turn promote cancer development.
Compliance with post-treatment surveillance, income level and the travel distance for follow-up care had effects on survival in patients with head and neck squamous cell cancer, according to a report.
Statin drugs can delay prostate cancer progression in patients receiving androgen deprivation therapy, study shows
Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial shows.
Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested for the presence of genes linked to various cancers, according to a recent study. Concern for uncertainty and potential distress were cited among the most common reasons to refuse testing.
Melanoma is aggressive and life-threatening. If it is not detected early, the prospects of recovery drop. Screening is complicated, though. Together with several project partners, researchers have developed an assistance system that helps dermatologists with diagnosis.
Tambahkan Komentar